Pacira BioSciences begins patient dosing in phase 2 study evaluating safety and efficacy of PCRX-201 to treat osteoarthritis of the knee: Brisbane, California Saturday, April 5, 2 ...

This therapy may be delivered through the use of an adeno-associated virus (AAV) vector. However, as trials with follow-up for AAV-mediated therapy have only just begun, Giulio Cossu, MD ...

Darcis examined the potential impact of climate change on vector-borne diseases, including malaria, dengue, Zika, and chikungunya. He emphasized the complexity of predicting these effects ...